Nebula Research & Development LLC Bausch Health Companies Inc. Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 56,100 shares of BHC stock, worth $445,995. This represents 0.05% of its overall portfolio holdings.
Number of Shares
56,100
Previous 144,832
61.27%
Holding current value
$445,995
Previous $1.01 Billion
54.65%
% of portfolio
0.05%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding BHC
# of Institutions
255Shares Held
253MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$276 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$234 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$210 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$124 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$103 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.88B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...